Glenmark introducing Remogliflozin + Vildagliptin combination first time in India
Glenmark Pharmaceuticals Limited is introducing a fixed dose combination (FDC) of Remogliflozin + Vildagliptin. Remogliflozin is Sodium Glucose Co-Transporter Inhibitor (SGLT2i). Sodium/glucose... Read More
Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx
Myovant Sciences is partnering with Pfizer to develop and commercialize Orgovyx for prostate cancer and women’s health. Orgovyx is the brand of... Read More
Insight on Aurobindo and COVAXX exclusive licensing agreement
Aurobindo and COVAXX, have entered into an Exclusive License Agreement to develop, commercialize and manufacture Covid-19 Vaccine. Aurobindo Pharma and COVAXX, a... Read More
Pfizer, BioNTech covid vaccine approval tilldate
Pfizer, BioNTech covid vaccine (BNT162b2) has received following marketing authorization* approval till date. UK Bahrain Canada Mexico US Singapore Oman Saudi Arabia... Read More
Chugai received MHLW, Japan marketing authorization for humanized anti-PD-L1 monoclonal antibody, Tecentriq to treat unresectable advanced/recurrent NSCLC
Posted on29 Dec 2020
Comments0
Chugai Pharmaceutical announced that it has obtained regulatory approval for its humanized anti-PD-L1 monoclonal antibody, Tecentriq Intravenous Infusion 1200 mg [generic name:... Read More
Lynparza received marketing authorization by MHLW, Japan to treat advanced ovarian, prostate and pancreatic cancers
AstraZeneca and MSD’s Lynparza (olaparib) has been approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers. The three... Read More
AstraZeneca – Alexion $39 billion deal
Posted on15 Dec 2020
Tagsacquisition in pharma, global pharma deals, largest ever pharma deal, monoclonal antibody, pharma deal, ravulizumab, Soliris, Ultomiris
Comments0
AstraZeneca has agreed to buy US drugmaker Alexion Pharmaceuticals for $39 billion to bolster its positions in immunology and rare diseases. Alexion... Read More
UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time
The UK today became the first country to approve the Covid-19 vaccine developed by Pfizer Inc and its German partner BioNTech SE.... Read More
Saudi Arabia signs non-binding vaccine agreement with CureVac
Saudi Arabia’s Pharmaceutical Industries and Medical supplies Corporation (Spimaco) signed a non-binding agreement with CureVac. CureVac is a German pharmaceutical company. CureVac... Read More
Telix Pharma to acquire TheraPharm GmbH
Telix Pharmaceuticals announced that it has entered into an agreement with Scintec Diagnostics GmbH (Scintec) to acquire TheraPharm GmbH, a Swiss-German biotechnology... Read More